Category: Health
-
Helfie Signs MOU with Homa Bay Kenya Ministry of Health for TB and Hypertension Screening Pilot
Population-scale pilot will target 100,000 of Homa Bay’s most vulnerable people across five sub-counties.MELBOURNE, Australia, Oct. 8, 2026 /PRNewswire/ — Helfie AI (“Helfie”), an AI-powered preventive network transforming global healthcare, today announced it has signed a Memorandum of Understandi…
-
SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
BOSTON, Oct. 8, 2026 /PRNewswire/ — SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) today announce a collaboration to advance new prostate cancer-specific genomic instability score (PrGIS) technology to support precision oncology approaches with AstraZeneca (LSE/STO/NYSE: A…
-
Zydus Hospitals, Ahmedabad, Takes Post-Weight-Loss Transformation Beyond the Scale
AHMEDABAD, India, Oct. 8, 2026 /PRNewswire/ — India is in the middle of a significant obesity crisis, and global estimates place the country third in the world for the number of adults living with obesity. Despite regular exercise, there are thousands of patients who struggle to lose weight, which …
-
OCI N.V. Notes Enterprise Chamber Decision Not to Order Inquiry
AMSTERDAM, Oct. 7, 2026 /PRNewswire/ — OCI N.V. (“OCI” or the “Company”) (Euronext: OCI) notes that the Enterprise Chamber of the Amsterdam Court of Appeal has today dismissed the petition brought by VEB and certain other shareholders and declined to order an inquiry into OCI’s policy and course of…
-
Apollo Clinical Research Conclave 2026 Explores the Future of Integrated Healthcare Innovation
~ Two-day national conclave brings together 350+ delegates to reimagine futuristic clinical research through innovation, technology, and collaboration ~NEW DELHI, Oct. 7, 2026 /PRNewswire/ — Apollo Research & Innovations successfully hosted the 4th edition of its flagship event, the Apollo Clin…
-
OncoBayes progressing OB-001 to tackle ADC resistance and TKI brain penetration
LONDON, Oct. 7, 2026 /PRNewswire/ — OncoBayes, a privately held clinical-stage pharmaceutical company, today announced the successful completion of preclinical work with OB-001, demonstrating the product’s potential to tackle two major unmet needs in oncology: ADC resistance and the brain penetrati…
-
Cambridge Heartwear Awarded £184 Million NHS Tender for World's First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable
CAMBRIDGE, England, Oct. 6, 2026 /PRNewswire/ — Cambridge Heartwear® Limited (www.camheartwear.com) has secured a landmark £184 million tender with the National Health Service (NHS) of the UK for HeartSense®, the world’s first medical-grade, multi-channel, portable, wirelessly charged ECG wearable …
-
ZEISS demonstrates new digital and visual enhancements across ophthalmic workflows at AAO
ZEISS Medical Technology will showcase its latest innovations and digital technologies at AAO, including:Connected cataract workflow –ZEISS VERACITY Surgery Planner reaches 3 million surgical cases planned through cloud-based software, supporting surgical efficiency built on automation and accurate …
-
Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth
SINGAPORE, Oct. 1, 2026 /PRNewswire/ — Emerald Clinical Trials, a leading global clinical research organization anchored in Asia-Pacific, today announced the appointment of Michael Stibilj as Chief Executive Officer, effective 1 October 2026. The appointment marks the beginning of the company’s nex…
-
Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month
Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. The development and manufacturing activities are being conducted at Piramal’s dedicated sterile injectable facility in Lexington, Kentucky. This partnership addresses ongoing cycl…
Latest News
About the Author
Publicize Your Brand
Through our news networks, we raise millions of users’ awareness. We are among the world’s most reputable news networks.
